Solventum (NYSE:SOLV) Shares Up 7.5% – Should You Buy?

Solventum Corporation (NYSE:SOLV) traded up 7.5% during trading on Tuesday . The company traded as high as $87.21 and last traded at $86.4990. Approximately 535,453 shares changed hands during trading, a decline of 62% from the average session volume of 1,396,965 shares. The stock had previously closed at $80.47.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Wells Fargo & Company decreased their price objective on Solventum from $83.00 to $70.00 and set an “equal weight” rating for the company in a research report on Wednesday, May 6th. Piper Sandler lowered their price objective on shares of Solventum from $98.00 to $92.00 and set an “overweight” rating for the company in a research report on Friday, April 17th. Wedbush initiated coverage on shares of Solventum in a research note on Friday, May 15th. They issued an “outperform” rating and a $94.00 target price for the company. BTIG Research restated a “buy” rating and issued a $91.00 price target on shares of Solventum in a report on Monday, July 13th. Finally, BMO Capital Markets initiated coverage on Solventum in a research report on Wednesday, July 8th. They set a “market perform” rating and a $81.00 price objective for the company. Seven equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $86.00.

Solventum Trading Up 6.7%

The business’s 50 day moving average price is $77.55 and its two-hundred day moving average price is $74.16. The company has a market capitalization of $14.87 billion, a price-to-earnings ratio of 10.48, a P/E/G ratio of 1.20 and a beta of 0.66. The company has a current ratio of 1.07, a quick ratio of 0.75 and a debt-to-equity ratio of 0.96.

Solventum (NYSE:SOLV) last issued its earnings results on Tuesday, May 5th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.35 by $0.13. The firm had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. Solventum had a net margin of 17.33% and a return on equity of 23.51%. The company’s quarterly revenue was down 3.0% on a year-over-year basis. During the same quarter last year, the business posted $1.34 earnings per share. Solventum has set its FY 2026 guidance at 6.600-6.600 EPS. On average, equities analysts predict that Solventum Corporation will post 6.58 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Solventum

A number of hedge funds have recently made changes to their positions in the stock. CrossGen Wealth LLC bought a new stake in shares of Solventum during the 4th quarter valued at about $25,000. Measured Wealth Private Client Group LLC acquired a new stake in shares of Solventum during the 3rd quarter worth approximately $25,000. Clearstead Trust LLC lifted its position in shares of Solventum by 61.0% during the 1st quarter. Clearstead Trust LLC now owns 396 shares of the company’s stock valued at $26,000 after acquiring an additional 150 shares during the period. JNBA Financial Advisors increased its stake in Solventum by 205.4% in the fourth quarter. JNBA Financial Advisors now owns 339 shares of the company’s stock valued at $27,000 after purchasing an additional 228 shares in the last quarter. Finally, CYBER HORNET ETFs LLC acquired a new position in shares of Solventum during the second quarter valued at about $28,000.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.